SUBSCRIBE
SUBSCRIBE

Parkinson’s disease

Pictured: Man holding a Chapter 11 bankruptcy filing
Deals
Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz
Acorda Therapeutics becomes the latest biotechnology company in 2024 to go bankrupt and shutter its business, following years of financial difficulty. Merz Therapeutics will acquire two commercial medicines from Acorda for $185 million.
April 3, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: 3D illustration of stem cells used for cell therapy
Business
Kenai Emerges from Stealth With $82M Series A, Targets Parkinson’s
Formerly known as Ryne Bio, Kenai Therapeutics emerged on Thursday with backing from several groups and has a cell therapy candidate going after Parkinson’s disease.
March 1, 2024
 · 
2 min read
 · 
Tyler Patchen
Load More
PRESS RELEASES
Press Releases
Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape
December 18, 2024
 · 
3 min read
Press Releases
Vandria announces first subjects dosed in its first-in-human Phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer
December 18, 2024
 · 
3 min read
Press Releases
Serina Therapeutics to Present at Tribe Public’s Webinar Event “Enabling Continuous Drug Delivery for Parkinson’s Disease & Beyond” on Wednesday, December 18, 2024
December 16, 2024
 · 
4 min read
Press Releases
7 Most Promising Drugs in Parkinson’s Disease Treatment Pipeline
December 10, 2024
 · 
1 min read
Press Releases
AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson’s Disease
December 9, 2024
 · 
9 min read
Press Releases
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease
December 6, 2024
 · 
6 min read
Press Releases
Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group
December 5, 2024
 · 
10 min read
Press Releases
Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group
December 4, 2024
 · 
3 min read
Press Releases
Spur Therapeutics Announces Development Candidate in Parkinson’s Disease Gene Therapy Program
December 4, 2024
 · 
5 min read
Press Releases
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients
December 3, 2024
 · 
5 min read
Press Releases
Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024
December 2, 2024
 · 
3 min read
Press Releases
S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial
November 26, 2024
 · 
5 min read
Press Releases
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson’s Disease
November 25, 2024
 · 
9 min read
Press Releases
CND Life Sciences Receives Grant from The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People with Parkinson’s Disease
November 20, 2024
 · 
4 min read
Press Releases
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
November 19, 2024
 · 
3 min read
Press Releases
Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease
November 19, 2024
 · 
7 min read
Press Releases
TrueBinding Receives FDA IND Go Ahead for Parkinson’s Phase 2A Clinical Trial
November 19, 2024
 · 
6 min read
Press Releases
Cerevance Doses First Patient in Pivotal Phase 3 ARISE Trial of Solengepras for Treatment of Parkinson’s Disease
November 18, 2024
 · 
4 min read
Press Releases
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
November 14, 2024
 · 
5 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
 · 
4 min read
Load More